StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Earnings

Emmaus Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 13, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$6.30M
+125.0% on a year earlier
EPS, Q2 FY2026
$0.02
-$0.02 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Emmaus Life Sciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 13, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 14, 2026during market hours$6.30M+125.0%$0.02Release
Q1 FY2026ended Mar 31, 2026May 15, 2026during market hours$2.00M–-$0.05Release
Q4 FY2025ended Dec 31, 2025Mar 31, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025during market hours$3.40M-38.2%-$0.03Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours$2.80M–-$0.02Release
Q4 FY2024ended Dec 31, 2024Apr 14, 2025during market hours–––Release
Q3 FY2024ended Sep 30, 2024Nov 19, 2024during market hours$5.50M–$0.03Release
Q2 FY2024ended Jun 30, 2024Sep 10, 2024during market hours–––Release
Q3 FY2023ended Sep 30, 2023Nov 14, 2023before the open–––Release
Q2 FY2023ended Jun 30, 2023Aug 14, 2023during market hours–––Release
Q1 FY2023ended Mar 31, 2023May 15, 2023before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Emmaus Life Sciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Emmaus Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Emmaus Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?